Advances in Clinical Chemistry, Volume 112 highlights new advances in the field, with this new volume presenting interesting chapters on a variety of timely topics, including Heterogeneity in Major Depressive Disorder: The need for Biomarker-based and Personalized Treatments, Advances in exosome analysis, Translational Proteomics and Phosphoproteomics: Tissue to Extracellular Vesicles, Immune Checkpoint Therapy, Tumor Immunology, and Biomarkers in Non-Small-Cell Lung Cancer, Advances in Congestive Heart Failure Biomarkers, Fluid biomarkers in Alzheimer's disease, and more.
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Table of Contents
- Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Shayam Suseelan and Graziano Pinna - Advances in exosome analysis
Arnau Pallares-Rusi�ol, Mireia Bernuz, Silio Lima Moura, Carolina Fern�ndez-Senac, Rosanna Rossi, Merc� Mart�, and Mar�a Isabel Pividori - Translational proteomics and phosphoproteomics: Tissue to extracellular vesicles
Xiaofeng Wu, Anton B. Iliuk, and W. Andy Tao - Immune checkpoint therapy and response biomarkers in non-small-cell lung cancer: Serum NY-ESO-1 and XAGE1 antibody as predictive and monitoring markers
Koji Kurose, Kanako Sakaeda, Minoru Fukuda, Yumiko Sakai, Hiroyuki Yamaguchi, Shinnosuke Takemoto, Katsuhiko Shimizu, Takeshi Masuda, Katsumi Nakatomi, Shigeo Kawase, Ryo Tanaka, Takayuki Suetsugu, Keiko Mizuno, Takehiro Hasegawa, Yusuke Atarashi, Yasuhiro Irino, Toshiyuki Sato, Hiromasa Inoue, Noboru Hattori, Eiichiro Kanda, Masao Nakata, Hiroshi Mukae, Toru Oga, and Mikio Oka - Advances in congestive heart failure biomarkers
Iyyapu Krishna Mohan, K.S.S. Sai Baba, Rohit Iyyapu, Sunitha Thirumalasetty, and O. Sai Satish - Fluid biomarkers in Alzheimer's disease
Joel Simr
Authors
Gregory S. Makowski Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA.Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.
